Fluticasone Propionate Market Size will reach to 5.6 mt in 2024

    Fluticasone Propionate belong to corticosteroids drugs. Fluticasone propionate powder is used to treat asthma. Fluticasone propionate spray is used to treat allergic rhinitis. Fluticasone propionate cream and ointment is used to treat pain, itching, and swelling caused by skin disease. It is first marketed by GSK. Fluticasone propionate API is used to produce finished drug including fluticasone propionate powder, fluticasone propionate spray, fluticasone propionate cream and ointment.

    The starting raw materials of fluticasone propionate is dimethylthiocarbamoyl chloride and bromofluoromethane which is used to produce the key Intermediate-Flumethasone. Then crude fluticasone propionate API is formed through a five-step chemical reaction started from flumethasone. Generally, 3.33 kg flumethasone can produce 1 kg fluticasone propionate.

    This report cover the Fluticasone Propionate industrial chain based on API. Following are the industrial chain structure:

Source: HDIN Research

    The fluticasone propionate market size is stable recently. The global fluticasone propionate finished product market size was 10.6 billion USD in 2018 which is the same as 2014 according IMS data. Global fluticasone propionate API market volume was estimated at 5.1 metric ton (mt) in 2018 and is forecasted to reach 5.6 mt in 2024, with a CAGR of 1.6% according to HDIN Research data.

Source: HDIN Research

    There are 9 Fluticasone Propionate API producers investigated in the report including Cipla, Sterling, Frmabios, Hovione, Hunan Norchem Pharma etc. The report also investigate end user of Fluticasone Propionate API such as GSK, TEVA, Mylan etc.